Recently， Space Peptides (Taizhou) Pharmaceutical Co., Ltd. (referred as ” Space Peptides (Taizhou)”) announced the completion of a strategic financing of millions of RMB. This round of financing is jointly invested by leading domestic pharmaceutical listed companies Shenyang Xingqi Pharmaceutical Co., Ltd., Yichang Humanwell Pharmaceutical Co., Ltd., Industry side: Xiamen Furier Pharmaceutical Co., Ltd., and emerging venture capital fund Purple Knight Capital, which focuses on the peptide field. This investment is also the first time that Shenyang Xingqi Pharmaceutical Co., Ltd. and Yichang Humanwell Pharmaceutical have laid out in the peptide field.
